Literature DB >> 25045596

Genetic Counseling for Diabetes Mellitus.

Stephanie A Stein1, Kristin L Maloney2, Toni I Pollin3.   

Abstract

Most diabetes is polygenic in etiology, with (type 1 diabetes, T1DM) or without (type 2 diabetes, T2DM) an autoimmune basis. Genetic counseling for diabetes generally focuses on providing empiric risk information based on family history and/or the effects of maternal hyperglycemia on pregnancy outcome. An estimated one to five percent of diabetes is monogenic in nature, e.g., maturity onset diabetes of the young (MODY), with molecular testing and etiology-based treatment available. However, recent studies show that most monogenic diabetes is misdiagnosed as T1DM or T2DM. While efforts are underway to increase the rate of diagnosis in the diabetes clinic, genetic counselors and clinical geneticists are in a prime position to identify monogenic cases through targeted questions during a family history combined with working in conjunction with diabetes professionals to diagnose and assure proper treatment and familial risk assessment for individuals with monogenic diabetes.

Entities:  

Keywords:  clinical genetics; diabetes; empiric risk; genetic counseling; genetics; genomics; gestational diabetes; maturity onset diabetes of the young, type 1 diabetes; monogenic diabetes; neonatal diabetes; syndromic diabetes; type 2 diabetes

Year:  2014        PMID: 25045596      PMCID: PMC4097380          DOI: 10.1007/s40142-014-0039-5

Source DB:  PubMed          Journal:  Curr Genet Med Rep        ISSN: 2167-4876


  92 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

2.  Treating diabetes mellitus in Prader-Willi syndrome with Exenatide.

Authors:  Ian W Seetho; Gavin Jones; George A Thomson; Devaka J S Fernando
Journal:  Diabetes Res Clin Pract       Date:  2011-01-11       Impact factor: 5.602

3.  Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q.

Authors:  G Velho; M Vaxillaire; V Boccio; G Charpentier; P Froguel
Journal:  Diabetes Care       Date:  1996-09       Impact factor: 19.112

4.  Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment.

Authors:  Nanna D Rendtorff; Marianne Lodahl; Houda Boulahbel; Ida R Johansen; Arti Pandya; Katherine O Welch; Virginia W Norris; Kathleen S Arnos; Maria Bitner-Glindzicz; Sarah B Emery; Marilyn B Mets; Toril Fagerheim; Kristina Eriksson; Lars Hansen; Helene Bruhn; Claes Möller; Sture Lindholm; Stefan Ensgaard; Marci M Lesperance; Lisbeth Tranebjaerg
Journal:  Am J Med Genet A       Date:  2011-04-28       Impact factor: 2.802

5.  Molecular Genetics of Maturity-onset Diabetes of the Young.

Authors: 
Journal:  Trends Endocrinol Metab       Date:  1999-05       Impact factor: 12.015

Review 6.  Role of molecular genetics in transforming diagnosis of diabetes mellitus.

Authors:  Anders Molven; Pål R Njølstad
Journal:  Expert Rev Mol Diagn       Date:  2011-04       Impact factor: 5.225

7.  KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.

Authors:  Anna L Gloyn; Catherine Diatloff-Zito; Emma L Edghill; Christine Bellanné-Chantelot; Sylvie Nivot; Régis Coutant; Sian Ellard; Andrew T Hattersley; Jean Jacques Robert
Journal:  Eur J Hum Genet       Date:  2006-05-03       Impact factor: 4.246

8.  Genetic risk profiling for prediction of type 2 diabetes.

Authors:  Raluca Mihaescu; James Meigs; Eric Sijbrands; A Cecile Janssens
Journal:  PLoS Curr       Date:  2011-01-11

9.  Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.

Authors:  Gaya Thanabalasingham; Aparna Pal; Mary P Selwood; Christina Dudley; Karen Fisher; Polly J Bingley; Sian Ellard; Andrew J Farmer; Mark I McCarthy; Katharine R Owen
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

10.  The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.

Authors:  William A Hagopian; Henry Erlich; Ake Lernmark; Marian Rewers; Anette G Ziegler; Olli Simell; Beena Akolkar; Robert Vogt; Alan Blair; Jorma Ilonen; Jeffrey Krischer; JinXiong She
Journal:  Pediatr Diabetes       Date:  2011-05-12       Impact factor: 3.409

View more
  7 in total

Review 1.  Personalized medicine in diabetes mellitus: current opportunities and future prospects.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

2.  Patient perspectives on the diagnostic journey to a monogenic diabetes diagnosis: Barriers and facilitators.

Authors:  Yue Guan; Kristin A Maloney; Toni I Pollin
Journal:  J Genet Couns       Date:  2020-03-12       Impact factor: 2.537

3.  Protein Glycosylation in Diabetes.

Authors:  Tamara Štambuk; Olga Gornik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 4.  The Genetic Architecture of Diabetes in Pregnancy: Implications for Clinical Practice.

Authors:  Jeffrey W Kleinberger; Kristin A Maloney; Toni I Pollin
Journal:  Am J Perinatol       Date:  2016-08-29       Impact factor: 1.862

5.  User-centered design of multi-gene sequencing panel reports for clinicians.

Authors:  Elizabeth Cutting; Meghan Banchero; Amber L Beitelshees; James J Cimino; Guilherme Del Fiol; Ayse P Gurses; Mark A Hoffman; Linda Jo Bone Jeng; Kensaku Kawamoto; Mark Kelemen; Harold Alan Pincus; Alan R Shuldiner; Marc S Williams; Toni I Pollin; Casey Lynnette Overby
Journal:  J Biomed Inform       Date:  2016-07-14       Impact factor: 6.317

Review 6.  Undiagnosed MODY: Time for Action.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

7.  Association of NF-E2 Related Factor 2 (Nrf2) and inflammatory cytokines in recent onset Type 2 Diabetes Mellitus.

Authors:  Dornadula Sireesh; Umapathy Dhamodharan; Krishnamoorthy Ezhilarasi; Viswanathan Vijay; Kunka Mohanram Ramkumar
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.